PYCR1 and lung adenocarcinoma: This study explored the role of PYCR1 in the physiological behavior of lung adenocarcinoma and the potential mechanism underlying the tumor cell resistance to cisplatin, which provided novel insights into lung adenocarcinoma to formulate strategies for the treatment.